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ABSTRACT 
Introduction: Brain vascular pathology, aneurysms, arteriovenous malformations 
(AVMs), cavernomas, dural arteriovenous fistulas (DAVF), venous angiomas and 
capillary telangiectasia, represents a serious health problem worldwide. 
Aim: The aim of this article is to perform an analysis of patients with brain vascular 
pathology and to analyze costs of health services, a research market for an 
entrepreneurial project, in order to design guidelines for patients’ selection and 
treatment. 
Material and methods: We performed an observational, descriptive study of 
patients with vascular pathology, from 2018 to 2019. 
Results: A total of 153 patients with brain vascular pathology were admitted in our 
department. Mean age was 49.53 ± 13.997 years. Sex ratio was 0.86. Mean hospital 
stay was 11.33 ± 13.724 days. Seventy-four patients (48.37%) underwent surgery. 
Seventy-eight patients (50.98%) had cerebral aneurysms. Complications were seen in 
24 patients (30.77%) and vasospasm in 32 cases (41.03%). Thirty-six patients 
underwent surgery. Outcome was favorable, according to mRS(p=0.001) and 
Karnofsky score(p=0.006). Thirty-three patients (21.57%) had brain AVMs. Twenty 
patients underwent surgery. Complications were seen in 4 cases (12.12%). The 
outcome was favourable, according to mRS(p=0.001) and Karnofsky score (p=0.002). 
Thirty-nine patients (25.49%) had cavernomas. Surgery was performed in 18 cases. 
The outcome was favourable, according to Engel Epilepsy Surgery Outcome Scale, 
mRS (p=0.000) and Karnofsky score (p =0.000). Costs of health services were 
correlated with longer hospitalization, higher mRS, lower Karnosfsky score, presence 
of complications and presence of vasospasm. 
Conclusions: Proper treatment of brain vascular pathology ensures a favourable 
outcome. Adequate patients’ selection and choosing the best treatment can reduce 
costs. Surgery is the treatment of choice in ruptured aneurysms, AVMs and 
cavernomas. Early surgery, with specific treatment of the vascular lesion and removal 
of intracranial blood ensures a better outcome, with lower medical costs. Prevention 
of complications, aggressive treatment of vasospasm reduces medical costs. 
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INTRODUCTION 
Brain vascular pathology is represented by 
aneurysms and vascular malformations. Vascular 
malformations are arteriovenous malformations 
(AVMs), cavernomas, duralarteriovenousfistulas 
(DAVF), venous angiomas and capillary 
telangiectasia.1 
Brain vascular pathology is a serious health 
problem world-wide. The incidence of cerebral 
aneurysms is 0.2-7.9% and the prevalence is 5%.2 The 
incidence of brain AVMs is 0.15-3%3,4 and the 
prevalence is 0.14%5,6. The incidence of  cavernomas 
is 0.15-0.56% and the prevalence is 0.17-0.9%.7 DAVF, 
venous angiomas and capillary telangiectasia are 
rare.  
Unfortunately brain vascular pathology occurs in 
young, active people and more than half of patients 
present with intracerebral hemorrhage, with 
significant morbidity and mortality. Peak incidence of 
aneurysms is 55-60 years2, AVMs become 
symptomatic in younger people, mean age is 33 
years5,6 and in cavernomas is 42 years8. The most 
common form of presentation is rupture with 
subsequent brain hemorrhage. Pattern of 
hemorrhage depends on type of vascular disease. 
Aneurysms usually rupture in the subarachnoid 
space, while AVMs and cavernomas cause 
intraparenchymatal hematoma. Regardless the type 
of intracerebral hemorrhage, all are major 
aggressive factors to the brain and carry important 
risks of death or development of serious 
neurological complications. Other forms of 
presentation are seizures, cranial nerves palsies, 
motor or sensory deficits, intracranial 
hyperpressure, ischemia, hydrocephalus, etc. 
Surgery is the treatment of choice for aneurysms, 
AVMs and cavernomas.9-11Even though a benign 
pathology, surgery for brain vascular pathology 
carries significant risks. For cerebral aneurysms 
embolization can also be tried.11 Besides surgery, 
AVMs also benefit from stereotactic radiosurgery 
and embolization. DAVF is usually treated through 
embolization and venous angiomas and capillary 
telangiectasia do not require treatment. 
The aim of this article is to perform an analysis of 
patients with brain vascular pathology and to analyze 
the costs of health services, a research market for an 
entrepreneurial project, in order to design guidelines 
for patients’ selection and treatment. 
 
MATERIAL AND METHODS 
We performed an observational, descriptive study in 
which we included patients with vascular pathology 
admitted in the IVth Department of Neurosurgery, 
Emergency Clinical Hospital Bagdasar-Arseni, from 
January 2018 to December 2019. Data were collected 
in a retrospective manner from January 2018 to 
August 2019 and prospectively from September 
2019 to December 2019. We collected data from 
hospital medical records and electronic health 
record Hipocrate. Statistic analysis of data was done 
using SPSS®.  
 
RESULTS  
A total of 153 patients with brain vascular pathology 
were admitted over a period of time of two years in 
the IVth Department of Neurosurgery, Emergency 
Clinical Hospital Bagdasar-Arseni from Bucharest, 
Romania.Patients with brain vascular pathology 
represented 2.09% from the total number of 
admissions in our department. 
Vascular brain pathology was represented by 
aneurysms, AVMs, cavernomas and DAVF. (Figure 1) 
Mean age of all patients with vascular pathology was 
49.53 ± 13.997 years. Sex ratio (M/F) was 0.86. Mean 
hospital stay was 11.33 ± 13.724 days. A total of 74 
patients (48.37%) underwent surgery. The rest of 73 
patients either had no indications for surgery, 
refused surgery or benefit from other nonoperative 
treatments.  
 
 
 
Figure 1. Types of brain vascular pathology. 
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Figure 2. Sex ratio per each type of vascular pathology. 
 
 
 
Figure 3. Basilar tip aneurysm. 
 
Aneurysms 
Seventy-eight patients (50.98%) were admitted with 
cerebral aneurysms. Mean age of these patients was 
53.73 ± 11.146 years. There were 53 women (67.95%) 
and 25 men (32.05%). Sixty-two patients (79.49%) 
had single aneurysm and 16 patients (20.51%) had 
multiple aneurysms. The latter 16 patients harbor a 
total number of 35 aneurysms, varying from 2 to 6 
lesions per patient. Aneurysms’ locations are shown 
in table 1. Forty-eight (61.54%) had ruptured 
aneurysms and only 30 people (38.46%) had 
unruptured ones. From the total number of patients 
with ruptured aneurysms, according to Hunt and 
Hess scale, 22 patients were grade I, 4 grade II, 3 
grade III, 8 grade IV and 11 grade V. According to 
Fisher scale, 2 patients had grade I, 17 grade II, 8 
grade III and 21 grade IV. Patients with ruptured 
aneurysms had the following pattern of brain 
hemorrhage: 45 had subarachnoid hemorrhage, 9 
had intraparenchymatal hematoma, 19 intra-
ventricular hemorrhage and 2 had subdural 
hematoma.   
Complications were seen in 24 patients (30.77%). 
Vasospasm, a fearful complication was seen in 32 
patients (41.03%). Vasospasmwas more commonly 
encountered in patients with higher grades on Hunt 
and Hess and Fisher scales (p=0.000, p=0.000). 
Thirty-six patients underwent surgery (34 
patients had their aneurysms clipped and in 2 
wrapping was done). Outcome was favorable, mRS at 
discharge were lower than mRSat admission (Z=-
3.426, p=0.001) and final Karnofsky scores were 
higher than initial scores (Z=-2.754, p=0.006). 
 
AVMs 
Thirty-three patients (21.57%) were admitted with 
brain AVMs. Mean age was 40.82± 14.501 years. 
There were 20 males (60.61%) and 13 females 
(39.39%). Sixteen patients (48.48%) presented with 
ruptured AVMs and 13 cases (39.39%) had history of 
seizures. According to brain hemorrhage pattern 12 
patients had intraparenchymatal hematoma, 4 had 
intraventricular hemorrhage, 3 had subarachnoid 
hemorrhage and only one had subdural hematoma. 
Motor deficit was encountered in 11 cases. According 
to Spetzler-Martin scale, 9 cases (27.27%) were grade 
I, 8 patients (24.24%) were grade II, 8 (24.24%) grade 
III, 3 patients (9.09%) were grade IV, 3 cases (9.09%) 
were grade V and 2 cases (6.06%) had grade VI AVMs. 
Three patients had flow-related associated 
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aneurysms. No patient presented cerebral 
vasospasm.  
Twenty patients underwent surgery, 5 cases 
underwent stereotactic radiosurgery Gamma Knife 
and 2 patients were embolized. Five patients refused 
surgery and 2 cases had grade VI Spetzler-Martin 
AVMs and did not benefit from therapy. 
Complications were seen in 4 cases (12.12%). 
Outcome was favorable, discharge mRSwere 
lower than admission mRS (Z=-3.332, p=0.001) and 
finalKarnofsky scores were higher than initial scores 
(Z=-3.047, p=0.002). 
 
 
 
Figure 4. Grade III Spetzler-Martin AVM.   
Cavernomas 
Thirty-nine patients (25.49%) were admitted with 
brain cavernomas. Mean age for patients with 
cerebral cavernomas was 48.28 ± 15.788. Sex ratio 
(M/F) was 1.6. Thirty-three patients (84.62%) had 
single cavernomas, but 6 (15.38%) had multiple 
lesions, the number of cavernomas varying from 3 to 
8. Ruptured cavernomas were found in 16 patients. 
According to the pattern of brain hemorrhage, all 16 
patients had intraparenchymatal hematoma, one 
associated intraventricular hemorrhage and one 
subdural hematoma. Nine patients had motor deficit 
and 10 cases were admitted with seizures.Positive 
diagnosis was done by MRI, T2 echo-gradient and 
FLAIR. Only 6 patients underwent DSA, and the 
angiography was negative in all cases. Surgery was 
performed in 18 cases. Deep cavernomas required 
intraoperative usage of ultrasound-based 
neuronavigation system Sonowand®. From the total 
of 10 patients with epilepsy, 6 underwent surgery, 
and 3 were free of disabling seizures (Engel IA) 
postoperative, 2 had worthwhile improvement 
(Engel IIIB) and one had no worthwhile improvement 
(Engel IVB). Outcome was favorable, according to 
mRS (Z=-4.274, p=0.000) and Karnofsky score (Z=-
4.283, p =0.000). 
 
 
Figure 5. Pontine cavernoma. 
 
Dural AV fistulas 
There were only 3 patients (1.96%) with DAVF. Mean 
age was 52.33 ± 4.933. 
 
 
 
 
 
 
 
 
Figure 6. DAVF type IV Merland-Cognard, injected from middle 
meningeal artery. 
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Total health care costs accounted for 3215558.4658 
lei, and they were composed by 2574452.06 lei 
hospitalization costs, 14067.4 lei food costs, 
15993.085 lei medication costs, 18641.038 lei blood 
work costs, 105797 lei imaging examinations costs. 
Hospital staywas positively correlated with 
hospitalization costs (p=0.000), food costs (p=0.000), 
medication costs (p=0.000), medical products costs 
(p=0.000), blood work costs (p=0.000), imaging 
examinations costs (0=0.002) and total cost of health 
care(p=0.000). Patients who underwent surgery have 
higher costs (p=0.000).Patients who presented 
complications and vasospasm have also higher costs 
(p=0.000, p=0.000). Higher mRS and lower Karnofsky 
score at admission were associated with higher costs 
(p=0.000, p=0.000). Another 575 days for 
postoperative controls were gathered with 
additional total costs of 638406.916 lei. 
 
DISCUSSIONS 
Brain vascular pathology was encountered in young, 
active patients, meanage for the entire group being 
under 50 years old, with differences for every 
pathology. 
Surgery for vascular lesions is challenging. Only 
50% of patients diagnosed with vascular pathology 
benefit from surgery. This low rate of patients with 
surgery is caused by several factors. Surgery is 
indicated when benefits are higher than risks, and 
we must not forget that we are dealing with high risk 
surgeries, so there are patients with grade VI AVMs, 
deep seated unruptured, asymptomatic cavernomas 
or unruptured ectatic vessels, in which surgery is not 
required. More, there are patients, or families who 
refused surgery after they were informed of the 
possible risks. And there is another group of patients 
who are not candidate for surgery. 
In case of brain aneurysms clipping is the curative 
treatment.11,12 Surgical technique depends on 
location, type and size of aneurysm and 
angioarchitecture of parental and efferent 
vessels.9One or more clips of different sizes can be 
used to secure the aneurysm (simple clipping, 
multiple clipping, tandem clipping, fenestration 
tubes, clip reconstruction).9Other surgical 
techniques are wrapping and trapping. Surgery for 
aneurysm must be performed early, to hinder the 
risk of rebleeding. 
Found almost exclusively in cerebral aneurysms, 
vasospasm is causing important morbidity. 
Vasospasm occurs between days 3 and 14 after 
subarachnoid hemorrhage onset, and it is due to 
presence of blood in the subarachnoid space, which 
induces arterial vasoconstriction. Vasospasm is 
associated with higher Fisher and Hunt and Hess 
grades. Many surgeons do not recommend surgery 
in this period of time because it increases the risk of 
vasospasm. Early intensive treatment for 
vasospasm, such as triple H therapy (hypertension, 
hypervolemia and hemodilution), intraoperative 
washing of all subarachnoid spaces from blood clots, 
calcium channel blockers (nimodipine) or 
angioplasty may reduce the incidence of vasospasm 
and its devastating consequences. So, ideally surgery 
is done early after rupture, before installation of 
vasospasm and postoperative medical treatment is 
initiated. But if patient is not admitted in a specialized 
center before day 3, timing for surgery is debatable. 
We recommend operating the patient even in the 
delicate period from day 3 to 14, because clipping the 
aneurysm allows intraoperative removal of blood 
clots and postoperative triple H therapy. In our 
opinion removal of subarachnoid blood, triple H 
therapy and nimodipine are the most effective 
treatments. Costs are influences by occurrence of 
complications, mainly vasospasm, so preventionof 
vasospasm reduces costs. Vasospasm is not found in 
patients with AVMs or cavernomas, because they do 
not bleed in the subarachnoid space, so for this 
group of patients,specific treatment for vasospasm is 
not indicated. 
Surgery is the treatment of choice in AVMs.13,14 
Complete resection ensures cure of the lesion. 
Stereotactic radiosurgery causes progressive 
occlusion of vessels, but unfortunately the effect 
occurs in time, and until 1-2 years the nidus is still 
active. Embolization is recommended only as 
adjuvant before surgery or in grade VI AVMs.14The 
effect of embolization is limited in time, surgery must 
be performed in the first week after occlusion 
procedure. After one month the nidus recruits new 
blood vessels. Principles of surgery for AVMs depend 
on location, Spetzler-Martin score and 
angioarchitecture of the lesion. We recommend 
surgery for all ruptured AVMs and in all lesions 
located in non-eloquent areas.15 Conservative 
treatment and stereotactic radiosurgery can be tried 
in patients with small, unruptured, located in 
eloquent areas AVMs.13 Surgical principles are 
represented by early coagulation of feeding arteries, 
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circumferential dissection of the nidus progressing 
deep and, after complete arterial disconnection of 
the nidus occlusion of draining veins.10We do not 
perform preoperative embolization of AVMs because 
it carries the risk of intraprocedural nidus rupture 
and developing normal perfusion pressure 
breakthrough. But other authors consider it helpful 
before surgery. 
The angiography was negative in all cases with 
cavernomas. They are considered to be occult 
angiographic lesions, because they have very low 
flow and do not enhance with contrast. We do not 
recommend angiography in cases suggestive for 
cavernomas. The imaging of choice is T2 echo-
gradient and FLAIR MRI. We recommend surgery in 
patients with ruptured cavernomas, with 
intraparenchymatal hematoma, in symptomatic 
cavernomas and in superficial accessible lesions. 
Deep, unruptured and asymptomatic cavernomas 
are kept under surveillance. For brainstem 
cavernomas, we strongly recommend surgery after 
the first bleeding, because the second has 
devastation consequences. In supratentorial 
cavernomas we recommend resection of 
hemosiderin ring surrounding the cavernoma. Brain 
surrounding the lesion impregnated with 
hemosiderin can be responsible for seizure 
persistence. So resection of hemosiderin ring 
ensures good outcome, evaluated through Engel 
Epilepsy Surgery Outcome Scale. In lesions located in 
the brainstem we recommend resection of the lesion 
leaving the hemosiderin ring in place. Infratentorial 
cavernomas do not produce seizure, and aggressive 
resection in this delicate area full with eloquent 
structures induces severe neurological deficits. 
We recommend embolization of DAVF.  
Total health care costs of patients is composed by 
hospitalization costs, food costs, medication costs, 
medical products costs, blood work costs and 
imaging exams costs.  
Longer hospitalization increases costs. Higher 
costs in the group of patients who underwent 
surgery compare with patients belonging to the 
conservative group, even if it is highly significant, it is 
not relevant because we are a neurosurgical 
department and we only keep patients for surgery. If 
a patient has no surgical indication or refuses 
surgery, we discharge him and he will be treated 
further in the territorial neurological department. So 
costs for nonsurgical patients are not adequately 
evaluated. So, we can conclude that our study 
illustrates best the surgical group. Food costs are 
bound to hospitalization cost and comorbidities (e.g. 
diabetes, renal failure, etc.). Usually blood work costs 
are not so high, we only take the minimum set before 
surgery. Vascular pathology does not require special, 
expensive blood test before surgery. It may increase 
if patients require repetitive blood analysis (e.g. 
postoperative anemia, patients in ICU, etc.). 
Unfortunately, other costs, such as costs with the 
medical personnel, cost of surgery or costs for days 
in the ICU, which are included in a bill from the 
private hospitals, are not included in a state hospital.   
Complications also increased costs. So, adequate 
patients’ selection and choosing the best treatment 
for lowering the rate of possible complications can 
reduce costs.  
Cost analysis is useful as a market research to 
predict resources needed for patients’ investigation 
and treatment. Such analysis is a useful tool in 
developing guidelines. The principles of guidelines 
choosing the best treatment, while optimizing health 
care services.  
A limit of the study is represented by the fact that 
it precisely illustrates the surgical group, but it is not 
so reliable in characterizing the conservative group. 
 
CONCLUSIONS 
Proper treatment of brain vascular pathology 
ensures a favorable outcome. Adequate patients’ 
selection and choosing the best treatment to lower 
the rate of possible complications can reduce costs. 
Surgery is the treatment of choice in ruptured 
aneurysms, AVMs or cavernomas. Early surgery, with 
specific treatment of the vascular lesion and removal 
of intracranial blood ensures a better outcome, with 
lower medical costs. Prevention of complications, 
aggressive treatment of vasospasm reduces medical 
costs. Further analysis is needed to perfect 
guidelines for treatment of patients with brain 
vascular pathology. 
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Table 1. Aneurysms’ location. 
 
 
Aneurysm location Single aneurysm Multiple aneurysms Total no. Total % 
ICA segm C4 3 1 4 4.12 
ICA segm C5 4 4 8 8.25 
ICA segm C6 10 10 20 20.62 
ICA segm C7 2 1 3 3.09 
ACoA 18 1 19 19.59 
ACA 5 3 8 8.25 
MCA 9 11 20 20.62 
ACoP 4 3 7 7.22 
SCA 1 0 1 1.03 
Basilar artery 4 1 5 5.15 
PICA 1 0 1 1.03 
Vertebral artery 1 0 1 1.03 
Total 62 35 97 100 
 
 
Table 2. AVMs’ location. 
 
AVM location Total no. Total % 
F 7 21.21 
T 4 12.12 
P 4 12.12 
O 5 15.15 
FP 3 9.09 
FT 1 3.03 
Sylvian fissure 1 3.03 
TP 3 9.09 
TPO 2 6.06 
Intraventricular 1 3.03 
Posterior fossa 2 6.06 
Total 33 100 
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ABBREVIATIONS  
ACA anterior cerebral artery 
ACoA anterior communicating artery 
ACoP anterior posterior artery 
AVM arteriovenous malformation 
DAVF dural arteriovenous fistula 
ICA internal carotid artery 
MCA middle cerebral artery 
mRS modified Rankin score 
PICA posteroinferior cerebellar artery 
SCA superior cerebellar artery 
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